Apple iSports Group, Inc. Stockholders Equity

Quick Answer Apple iSports Group, Inc. reported Stockholders Equity of -$6.37 million for fiscal year 2024. Apple iSports Group, Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2024 -$6.37M -20.0% 2023 -$5.31M -223.3% 2022 -$1.64M -1009.6% 2022 -$148.0K +6.7% 2021 -$158.7K -72.5% 2021 -$92.0K -14.4% 2020 -$80.4K +76.9% 2019 -$347.4K -33.4% … Read more

Apple iSports Group, Inc. Total Assets

Quick Answer Apple iSports Group, Inc. reported Total Assets of $272.1 thousand for fiscal year 2024. Apple iSports Group, Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2024 $272.1K +292.2% 2023 $69.4K +69.9% 2022 $40.8K +676.3% 2022 $5.3K +1090.3% 2021 $442.00 +342.0% 2020 $100.00 -97.5% 2019 $4.0K +20.0% 2018 $3.3K +545.9% … Read more

Apple iSports Group, Inc. Net Income

Quick Answer Apple iSports Group, Inc. reported Net Income of -$2.82 million for fiscal year 2024. Apple iSports Group, Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2024 -$2.82M +23.3% 2023 -$3.68M -134.3% 2022 -$1.57M -2704.0% 2022 -$56.0K -34.7% 2021 -$41.6K +62.9% 2020 -$111.9K -28.6% 2019 -$87.0K +26.4% 2018 -$118.2K +5.6% … Read more

Apple iSports Group, Inc. Diluted EPS

Quick Answer Apple iSports Group, Inc. reported Diluted EPS of $0.00 per share for fiscal year 2024. Apple iSports Group, Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2024 $0.00 +100.0% 2023 -$0.02 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY QoQ September 30, 2025 $0.01 — — June 30, … Read more

Apple iSports Group, Inc. Financial Summary

Quick Answer Apple iSports Group, Inc. reported Total Revenue of $0.00 for fiscal year 2024. Apple iSports Group, Inc. — Key Financials by Year Metric 2024 2023 2022 2021 2020 2019 Total Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 Net Income -$2.82M+23.3% -$3.68M-6469.0% -$56.0K-34.7% -$41.6K+62.9% -$111.9K-28.6% -$87.0K+26.4% Diluted EPS $0.00+100.0% -$0.02 — — — — … Read more

ASCENTAGE PHARMA GROUP INTERNATIONAL Gross Profit

Quick Answer ASCENTAGE PHARMA GROUP INTERNATIONAL reported Gross Profit of $951.57 million for fiscal year 2024. ASCENTAGE PHARMA GROUP INTERNATIONAL Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2024 $951.57M +397.1% 2023 $191.44M +2.0% 2022 $187.71M — ASCENTAGE PHARMA GROUP INTERNATIONAL showed an increase of +397.1% in Gross Profit compared to the … Read more

ASCENTAGE PHARMA GROUP INTERNATIONAL R&D Expense

Quick Answer ASCENTAGE PHARMA GROUP INTERNATIONAL reported R&D Expense of $947.25 million for fiscal year 2024. ASCENTAGE PHARMA GROUP INTERNATIONAL R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2024 $947.25M +34.0% 2023 $706.97M -4.9% 2022 $743.10M — ASCENTAGE PHARMA GROUP INTERNATIONAL showed an increase of +34.0% in R&D Expense compared to the … Read more

ASCENTAGE PHARMA GROUP INTERNATIONAL Financial Summary

Quick Answer ASCENTAGE PHARMA GROUP INTERNATIONAL reported R&D Expense of $947.25 million for fiscal year 2024. ASCENTAGE PHARMA GROUP INTERNATIONAL — Key Financials by Year Metric 2024 2023 2022 R&D Expense $947.25M+34.0% $706.97M-4.9% $743.10M Gross Profit $951.57M+397.1% $191.44M+2.0% $187.71M ASCENTAGE PHARMA GROUP INTERNATIONAL reported R&D Expense of $947.25 million for fiscal year 2024. ASCENTAGE PHARMA … Read more